Galaxy Medicare Complete Financial Statements

In FYNone, Galaxy Medicare (GML) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 7.5% and ROE of 12.5%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Galaxy Medicare share price chart.

5 Years of Data
2025 - 2021

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.50% 2025 data
EBITDA Margin 15.00% 2025 data
Operating Margin 12.00% 2025 data
Return on Assets 9.38% 2025 data
Return on Equity 12.50% 2025 data

Balance Sheet Ratios

Current Ratio 15.00 2025 data
Equity Ratio 75.00% 2025 data
Asset Turnover 1.25 2025 data

GML Revenue, Net Profit & EBITDA — Year-on-Year Growth

GML YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-3.0%
Year-over-Year
Equity Growth
+14.3%
Year-over-Year
Operating Cash Flow Growth
+66.7%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-150.0%
Year-over-Year

GML Income Statement — Revenue, EBITDA & Net Profit

Galaxy Medicare revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 7.5%. Explore GML fundamental worth to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 0 40 37 32 31 29
Expenses 0 35 31 29 27 27
EBITDA 0 6 6 3 3 3
Operating Profit Margin % 0.00% 12.00% 14.00% 7.00% 8.00% 7.00%
Depreciation 0 1 1 1 1 1
Interest 0 1 1 1 1 1
Profit Before Tax 0 5 5 2 0 1
Tax 0 1 1 0 0 0
Net Profit 0 3 4 2 0 1
Earnings Per Share (₹) 0.00 2.84 3.13 5.17 -0.70 2.56

GML Balance Sheet — Assets, Liabilities & Shareholders' Equity

GML total assets ₹32 Cr, total equity ₹24 Cr, total liabilities ₹ Cr (2025) — ROE 12.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021
ASSETS
Total Assets 32 33 32 31 30
Current Assets 15 15 15 14 13
Fixed Assets 14 14 14 15 14
Capital Work in Progress 0 0 0 0 0
Investments 0 0 0 0 0
Other Assets 17 18 18 16 16
LIABILITIES
Total Liabilities
Current Liabilities 1 2 3 4 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 24 21 18 16 16
Share Capital 12 12 3 3 3
Reserves & Surplus 12 10 15 13 13

GML Cash Flow Statement — Operating, Investing & Financing

Galaxy Medicare operating cash flow ₹5 Cr, investing ₹0 Cr, financing ₹-5 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities 5 3 4 -1 6
Investing Activities 0 -1 -2 -1 -5
Financing Activities -5 -2 -2 1 -1
Net Cash Flow 0 0 0 0 0